AstraZeneca gets CDSCO nod for drug to treat biliary tract cancer

AstraZeneca gets CDSCO nod for drug to treat biliary tract cancer BTC is a group of rare and aggressive gastrointestinal (GI) cancers that form in the cells of the bile ducts (cholangiocarcinoma), gallbladder or ampulla of Vater (where the bile duct and pancreatic duct connect to the small intestine).

from Moneycontrol Business News https://www.moneycontrol.com/news/business/astrazeneca-gets-cdsco-nod-for-drug-to-treat-biliary-tract-cancer_16893681.html
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...